Recovery from alpha coma after decompression sickness complicated by spinal cord lesions at cervical and midthoracic levels.

V. Synek,G. Glasgow

DOI: https://doi.org/10.1016/0013-4694(85)91015-6

1985-05-01

Electroencephalography and Clinical Neurophysiology

Abstract:

What problem does this paper attempt to address?

A System for Probabilistic Inductive Answer Set Programming

Matthias Nickles,A. Mileo

DOI: https://doi.org/10.1007/978-3-319-23540-0_7

2015-09-16

Abstract:
Design, synthesis, QSAR modelling and molecular dynamic simulations of N-tosyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors

Zahra Batool,Saeed Ullah,Ajmal Khan,Suraj N. Mali,Shailesh S. Gurav,Rahul D. Jawarkar,Abdulrahman Alshammari,Norah A. Albekairi,Ahmed Al-Harrasi,Zahid Shafiq

DOI: https://doi.org/10.1038/s41598-024-75100-1

IF: 4.6

2024-10-29

Scientific Reports

Abstract:Tyrosinase is an enzyme crucial for the progression of melanogenesis. Immoderate production of melanin may be the cause of hyperpigmentation and darkening leading to skin diseases. Tyrosinase is the most researched target for suppressing melanogenesis since it catalyzes the rate-limiting stage of melanin production. Thiosemicarbazones have been reported to possess strong inhibition capability against tyrosinase. We have designed and synthesized eighteen N-tosyl substituted indole-based thiosemicarbazones as competitive tyrosinase inhibitors in the current work. All the compounds exhibited outstanding to good potency with half maximal inhibitory concentration in the range of 6.40 ± 0.21 μM to 61.84 ± 1.47 μM. The compound 5r displayed the top-tier inhibition amongst the entire series with IC 50 = 6.40 ± 0.21 μM. Compounds, 5q and 5r exhibited competitive inhibitions in concentration dependent manner with Ki = 3.42 ± 0.03 and 10.25 ± 0.08 μM respectively. The binding mode of 5r was evaluated through in silico molecular dynamics simulations and molecular docking, while ADME assessment studies predicted the drug-like characteristics of the derivatives. The newly synthesized derivatives may serve as a structural guide for designing and developing novel tyrosinase inhibitors.

multidisciplinary sciences
Design, synthesis, and in vitro and in silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors

Zahra Batool,Saeed Ullah,Ajmal Khan,Farhan Siddique,Sumaira Nadeem,Abdulrahman Alshammari,Norah A Albekairi,Rimsha Talib,Ahmed Al-Harrasi,Zahid Shafiq

DOI: https://doi.org/10.1039/d4ra05015k

2024-09-06

Abstract:Developing new anti-tyrosinase drugs seems crucial for the medical and industrial fields since irregular melanin synthesis is linked to the resurgence of several skin conditions, including melanoma, and the browning of fruits and vegetables. A novel series of N-1 and C-3 substituted indole-based thiosemicarbazones 5(a-r) are synthesized and further analyzed for their inhibition potential against tyrosinase enzyme through in vitro assays. The synthesized compounds displayed very good to moderate inhibition with half maximal inhibitory concentration in the range of 12.40 ± 0.26 μM to 47.24 ± 1.27 μM. Among all the derivatives 5k displayed the highest inhibitory activity. According to SAR analysis, the derivatives with 4-substitution at the benzyl or phenyl ring of the thiosemicarbazones exhibited better inhibitory potential against tyrosinase. In silico analysis (including ADMET prediction and molecular docking) was conducted and compared with the standard drug (kojic acid). These findings may help the hunt for new melanogenesis inhibitors that the food and cosmetics industries may find valuable.
Design, Synthesis, Structural Insights, Tyrosinase Inhibition, and Sun Protection Factor of New Thiosemicarbazone Derivatives

Sebastiano Masuri,Benedetta Era,Francesca Pintus,Sonia Floris,Francesca Meloni,Francesca Pettinau,Enrico Podda,Maria Grazia Cabiddu,Antonella Fais,Tiziana Pivetta

DOI: https://doi.org/10.3390/molecules29235629

IF: 4.6

2024-11-29

Molecules

Abstract:Tyrosinase, a key protein in the biosynthesis of melanin pigments, is crucial in determining skin pigmentation. Inhibiting tyrosinase activity is a promising approach for treating conditions related to excessive pigmentation. For the synthesis of more potent tyrosinase inhibitors, we combined two approaches, para-substitution and lipophilicity, to enhance the inhibitory properties of (E)-2-(4-hydroxybenzylidene)hydrazine-1-carbotiamide, whose enzyme inhibitory properties have been previously demonstrated. The newly synthesized compounds showed potent inhibition activity against tyrosinase in the micromolar concentration range. The synthesised compounds were up to 41 times more effective than kojic acid. In addition to this biological activity, all molecules were evaluated for their sun protection factor to determine their photoprotective effects. All the compounds showed higher efficacy than reference compounds, used as sunscreens in photoprotective preparations. All compounds were noncytotoxic at the concentration required to inhibit tyrosinase activity. With the aim of defining the potential binding modes and the kind of interactions between the studied molecules and the catalytic site of mushroom tyrosinase, molecular docking simulations were also performed.

chemistry, multidisciplinary,biochemistry & molecular biology
Design, synthesis, and molecular dynamics simulation studies of some novel kojic acid fused 2-amino-3-cyano-4H-pyran derivatives as tyrosinase inhibitors

Zahra Najafi,Maryam Zandi Haramabadi,Gholamabbas Chehardoli,Ahmad Ebadi‬,Aida Iraji

DOI: https://doi.org/10.1186/s13065-024-01134-1

2024-02-23

BMC Chemistry

Abstract:A novel series of kojic acid fused 2-amino-3-cyano-4H-pyran derivatives were synthesized via a multicomponent reaction involving kojic acid, benzyloxy benzaldehyde, and malonitrile as tyrosinase inhibitors. Subsequently, the structures of the compounds were characterized using FT-IR, 1 H-, and 13 C-NMR spectroscopic analyses. The designed compounds fall into three series: (1) 4-benzyloxy-phenyl kojopyran 6a – e , (2) 3-benzyloxy- phenyl kojopyran derivatives 6f – j , and (3) 4-benzyloxy-3-methoxy-phenyl kojopyran derivative 6 k – o . The assessment of tyrosinase inhibition activity was conducted using L-Dopa as the substrate. Among synthesized compounds, 2-amino-4-(4-((4-fluorobenzyl)oxy)phenyl)-6-(hydroxymethyl)-8-oxo-4,8-dihydropyrano[3,2- b ]pyran-3-carbonitrile ( 6b ) demonstrated the highest antityrosinase activity with a competitive inhibition pattern (IC 50 = 7.69 ± 1.99 μM) as compared to the control agent kojic acid (IC 50 = 23.64 ± 2.56 μM). Since compound 6b was synthesized as a racemic mixture, in silico studies were performed for both R and S enantiomers. The R - enantiomer showed critical interactions compared with the S -enantiomer. Specifically, it established hydrogen bonds and hydrophobic interactions with crucial and highly conserved amino acids within the enzyme's binding site in the target protein. Moreover, the molecular dynamics simulations revealed that compound 6b demonstrated significant interactions with essential residues of the binding site, resulting in a stable complex throughout the entire simulation run. The drug-like and ADMET properties predictions showed an acceptable profile for compound 6b . Thus, it can serve as a drug candidate to develop more potent antityrosinase agents due to its low toxicity and its high inhibition activity.

chemistry, multidisciplinary
Design and synthesis of novel dihydropyridine- and benzylideneimine-based tyrosinase inhibitors

Ifraz Ahmad,Warda Parveen,Shah Noor,Zahoor Udin,Amjad Ali,Ijaz Ali,Riaz Ullah,Hamid Ali

DOI: https://doi.org/10.3389/fphar.2024.1332184

IF: 5.6

2024-03-27

Frontiers in Pharmacology

Abstract:Tyrosinase (TYR) inhibitors are very significant as they inhibit enzyme tyrosinase activity, and its inhibition is vital for skin care, anticancer medication, and antibrowning of fruits and vegetables. This work presents a novel and economical route for the preparation of new synthetic tyrosinase inhibitors using amlodipine (4) . The novel conjugates 6 (a–o) were designed, synthesized, and characterized by spectroscopic analyses, including Fourier transform infrared and low- and high-resolution mass spectroscopy. The purified compound 4 was refluxed with various aldehydes and ketones 5 (a–o) for 5–8 h in methanol at 60°C–90°C. This research modified the drug in a step-by-step manner to develop therapeutic properties as a tyrosinase inhibitor. The structures of synthesized ligands 6 (a–o) were established based on spectral and analytical data. The synthesized compounds 6 (a–o) were screened against tyrosinase enzyme. Kojic acid was taken as standard. All the prepared compounds 6 (a–o) have good inhibition potential against the enzyme tyrosinase. Compounds 6o , 6b , 6f , and 6k depicted excellent antityrosinase activity. Compound 6k , with an IC 50 value of 5.34 ± 0.58 μM, is as potent as the standard kojic acid (IC 50 6.04 ± 0.11 μM), standing out among all synthesized compounds 6 (a–o) . The in silico studies of the conjugates 6 (a–o) were evaluated via PatchDock . Compound 6k showed a binding affinity score of 8,999 and an atomic contact energy (ACE) value of −219.66 kcal/mol. The structure–activity relationship illustrated that the presence of dihydropyridine nuclei and some activating groups at the ortho and para positions of the benzylideneimine moiety is the main factor for good tyrosinase activity. The compound 6k could be used as a lead compound for drug modification as a tyrosinase inhibitor for skin care, anticancer medication, and antibrowning for fruits and vegetables.

pharmacology & pharmacy
Synthesis and biological assessment of novel 4H-chromene-3-carbonitrile derivatives as tyrosinase inhibitors

Mohammad Azimi,Zahra Najafi,Asrin Bahmani,Gholamabbas Chehardoli,Aida Iraji

DOI: https://doi.org/10.1186/s13065-024-01305-0

2024-09-29

BMC Chemistry

Abstract:Excessive activity of the tyrosinase enzyme during melanogenesis results in hyperpigmentation in the skin. To address this issue, there is a need to develop effective tyrosinase inhibitors as a treatment for hyperpigmentation. In this study, we synthesized some novel 4 H -chromene-3-carbonitrile compounds ( 6a-o ) and assessed their inhibitory activities against tyrosinase, comparing them with kojic acid, which is known as a positive control. Compound 6f emerged as the most effective inhibitor, with an IC 50 of 35.38 ± 2.12 μM. Kinetic studies of 6f exhibited competitive inhibition, with K i = 16.15 μM. Molecular docking studies highlighted the importance of π-π stacking and hydrogen bonding interactions within the binding site. Molecular dynamics simulations showed that the R -enantiomer 6f exhibited superior binding stability compared to the S -enantiomer, with a lower standard deviation of RMSD and more persistent interactions with the key active site residues. These findings underscore the potential of the R -enantiomer of compound 6f as a potent tyrosinase inhibitor and provide insights for developing effective treatments for hyperpigmentation and related skin conditions.

chemistry, multidisciplinary
Nitrophenylpiperazine derivatives as novel tyrosinase inhibitors: design, synthesis, and in silico evaluations

Mehdi Asadi,Fahime Fayazi,Aida Iraji,Reyhaneh Sabourian,Homa Azizian,Mannan Hajimahmoodi,Bagher Larijani,Mohammad Mahdavi,Massoud Amanlou

DOI: https://doi.org/10.1186/s13065-024-01167-6

2024-04-06

BMC Chemistry

Abstract:A novel series of 4-nitrophenylpiperazine derivatives ( 4a – m ) was designed and synthesized as potential tyrosinase inhibitors. Comprehensive characterization using 1 H-NMR, 13 C-NMR, CNH, and IR techniques was performed for all target compounds. Subsequently, the derivatives were evaluated for their inhibitory activity against tyrosinase. Among them, compound 4l , featuring an indole moiety at the N−1 position of the piperazine ring, exhibited a significant tyrosinase inhibitory effect with an IC 50 value of 72.55 μM. Enzyme kinetics analysis revealed that 4l displayed mixed inhibition of the tyrosinase enzymatic reaction. Molecular docking was carried out in the enzyme's active site to further investigate the enzyme-inhibitor interactions. Based on the findings, compound 4l shows promise as a lead structure for the design of potent tyrosinase inhibitors. This study paves the way for the development of more effective tyrosinase inhibitors for potential applications in various fields.

chemistry, multidisciplinary
[Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan].

Y. Tsuji,Takahiro Nakayama,Keiko Bono,M. Kitamura,I. Imafuku

DOI: https://doi.org/10.5692/CLINICALNEUROL.54.423

Abstract:We report two cases of stroke associated with the use of finasteride at 1 mg/day, which is approved in Japan for the treatment of male-pattern hair loss. The first case involved a 35-year-old male taking 1 mg of finasteride daily for 6 months to prevent male-pattern hair loss. He was taken to a hospital and later admitted to our hospital owing to headache and seizures. Brain computed tomography (CT) images showed a low-density area in the right frontal lobe. CT venography (CTV) revealed sinus thrombosis and he was treated with an anticoagulant. As the headache gradually subsided, medications were tapered and terminated 10 months later when venous flow to the sagittal sinus and left transverse sinus was confirmed to be recanalized. The second case involved a 41-year-old male taking 1 mg of finasteride and 6 mg of minoxidil daily for 1 year for male-pattern hair loss. He started having headaches and was admitted to our hospital when diffusion-weighted images of brain magnetic resonance imaging (MRI) showed a high-intensity area in the left parietotemporal lobe. He was treated with antiplatelet and anticoagulation medicines. The Japan Pharmaceutical and Medical Devices Agency (PMDA) has reported 14 cases of thrombosis in patients taking finasteride in Japan; 4 cases of stroke (our 2 cases and 2 reported by PMDA), 6 cases of myocardial infarction, and 4 cases of other thrombotic diseases. Increases in estrone and estradiol levels in prostate cancer patients and controls receiving 5 mg of finasteride have been reported. Gynecomastia has also been reported as one of the adverse effects of finasteride at 1 mg or 5 mg daily. Taken together, we assume that the increases in estrone and estradiol levels induced by finasteride lead to thrombosis development.
Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study

Azzam Bagheri,Shahram Moradi,Aida Iraji,Mohammad Mahdavi

DOI: https://doi.org/10.1038/s41598-024-52022-6

IF: 4.6

2024-01-19

Scientific Reports

Abstract:A series of new analogs of 3,5-dihydroxybenzoyl-hydrazineylidene conjugated to different methoxyphenyl triazole ( 11a-n ) synthesized using click reaction. The structures of all synthesized compounds were characterized by FTIR, 1 H, 13 C-NMR spectroscopy, and CHO analysis. The tyrosinase inhibitory potential of the synthesized compounds was studied. The newly synthesized scaffolds were found to illustrate the variable degree of the inhibitory profile, and the most potent analog of this series was that one bearing 4-methoxyphenyl moiety, and exhibited an IC 50 value of 55.39 ± 4.93 μM. The kinetic study of the most potent derivative reveals a competitive mode of inhibition. Next, molecular docking studies were performed to understand the potent inhibitor's binding mode within the enzyme's binding site. Molecular dynamics simulations were accomplished to further investigate the orientation and binding interaction over time and the stability of the 11m -tyrosinase complex.

multidisciplinary sciences
Inhibitory Effects, Fluorescence Studies, and Molecular Docking Analysis of Some Novel Pyridine-Based Compounds on Mushroom Tyrosinase

Elahe Lotfi Shahpar,Atiyeh Mahdavi,Zahra Mohamadnia

DOI: https://doi.org/10.1021/acs.biochem.4c00204

IF: 3.321

2024-08-20

Biochemistry

Abstract:Melanin biosynthesis in different organisms is performed by a tyrosinase action. Excessive enzyme activity and pigment accumulation result in different diseases and disorders including skin cancers, blemishes, and darkening. In fruits and vegetables, it causes unwanted browning of these products and reduces their appearance quality and economic value. Inhibiting enzyme activity and finding novel powerful and safe inhibitors are highly important in agriculture, food, medical, and pharmaceutical industries. In this regard, in the present study, some novel synthetic pyridine-based compounds including 2,6-bis (tosyloxymethyl) pyridine (compound 3), 2,6-bis (butylthiomethyl) pyridine (compound 4), and 2,6-bis (phenylthiomethyl) pyridine (compound 5) were synthesized for the first time, and their inhibitory potencies were assessed on mushroom tyrosinase diphenolase activity. The results showed that while all tested compounds significantly decreased the enzyme activity, compounds 4 and 5 had the highest inhibitory effects (respectively, 80 and 89% inhibition with the IC50 values of 17.0 and 9.0 μmol L-1), and the inhibition mechanism was mixed-type for both compounds. Ligand-binding studies were carried out by fluorescence quenching and molecular docking methods to investigate the enzyme-compound interactions. Fluorescence quenching results revealed that the compounds can form nonfluorescent complexes with the enzyme and result in quenching of its intrinsic emission by the static process. Molecular docking analyses predicted the binding positions and the amino acid residues involved in the interactions. These compounds appear to be suitable candidates for more studies on tyrosinase inhibition.
Design and synthesis of novel hydroxypyridinone derivatives as potential tyrosinase inhibitors

De-Yin Zhao,Ming-Xia Zhang,Xiaowu Dong,Yongzhou Hu,Xiao-Yan Dai,Xiao-Yi Wei,Robert C. Hider,Jinchao Zhang,Tao Zhou

DOI: https://doi.org/10.1016/j.bmcl.2016.05.006

IF: 2.94

2016-01-01

Bioorganic & Medicinal Chemistry Letters

Abstract:Two groups of novel hydroxypyridinone derivatives 6(a–e) and 12(a–c), were designed as potential tyrosinase inhibitors, and synthesized using kojic acid as a starting material. The tyrosinase inhibitory activity of these two groups was demonstrated to be potent, especially compounds 6e and 12a, whose IC50 values for monophenolase activity were 1.95μM and 2.79μM, respectively. Both of these values are lower than that of kojic acid (IC50=12.50μM). Compounds 6e and 12a were investigated for the inhibitory effect on diphenolase activity. The results showed that the inhibitory mechanism of these two compounds was reversible and that the inhibitory type was a competitive-uncompetitive mixed-type. The values of IC50 of 6e and 12a on the diphenolase activity of tyrosinase were determined to be 8.97μM and 26.20μM, respectively. The inhibitory constants (KI and KIS) of 6e were determined as 17.17μM and 22.09μM, respectively; and the KI and KIS values of 12a were 34.41μM and 79.02μM, respectively. Compound 6e showed a greater ability to reduce copper and a stronger copper chelating ability than kojic acid.
Design, Synthesis, and Anti-Melanogenic Activity of 2-Mercaptomethylbenzo[d]imidazole Derivatives Serving as Tyrosinase Inhibitors: An In Silico, In Vitro, and In Vivo Exploration

Jung,Park,Kim,Park,Park,Chun,Chung,Moon

DOI: https://doi.org/10.3390/antiox13101248

IF: 7.675

2024-10-17

Antioxidants

Abstract:2-Mercaptomethylbenzo[d]imidazole (2-MMBI) derivatives were designed and synthesized as tyrosinase (TYR) chelators using 2-mercaptomethylimidazole scaffolds. Seven of the ten 2-MMBI derivatives exhibited stronger inhibition of mushroom TYR activity than kojic acid. Their ability to chelate copper ions was demonstrated through experiments using the copper chelator pyrocatechol violet and assays measuring TYR activity in the presence or absence of exogenous CuSO4. The inhibition mechanisms of derivatives 1, 3, 8, and 9, which showed excellent TYR inhibitory activity, were elucidated through kinetic studies and supported by the docking simulation results. Derivatives 3, 7, 8, and 10 significantly inhibited cellular TYR activity and melanin production in B16F10 cells in a dose-dependent manner, with stronger potency than kojic acid. Furthermore, in situ, derivatives 7 and 10 showed stronger inhibitory effects on B16F10 cell TYR activity than kojic acid. Six derivatives, including 8, showed highly potent depigmentation in zebrafish larvae, outpacing kojic acid even at 200–670 times lower concentrations. Additionally, all derivatives could scavenge for reactive oxygen species without causing cytotoxicity in epidermal cells. These results suggested that 2-MMBI derivatives are promising anti-melanogenic agents.

biochemistry & molecular biology,chemistry, medicinal,food science & technology
Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase

Zaman Ashraf,Muhammad Rafiq,Sung-Yum Seo,Kang Sung Kwon,Mustafeez Mujtaba Babar,Najam-us-Sahar Sadaf Zaidi

DOI: https://doi.org/10.1016/j.ejmech.2015.05.031

2015-06-15

Abstract:The present studies reports the synthesis of hydoxylated thymol analogues (4a-e) and (6a-c) as mushroom tyrosinase inhibitors. The title compounds were obtained in good yield and characterized by FTIR, (1)H NMR, (13)C NMR, Mass spectral data and X-ray crystallography in case of compound (6a). The inhibitory effects on mushroom tyrosinase and DPPH were evaluated and it was observed that 2-[5-methyl-2-(propan-2-yl)phenoxy]-2-oxoethyl (2E)-3-(4-hydroxyphenyl)prop-2-enoate (6b) showed tyrosinase inhibitory activity (IC50 15.20 μM) comparable to kojic acid (IC50 16.69 μM) while 2-[5-methyl-2-(propan-2-yl)phenoxy]-2-oxoethyl 3,4-dihydroxybenzoate (4d) exhibited higher antioxidant potential (IC50 11.30 μM) than standard ascorbic acid (IC50 24.20 μM). The docking studies of synthesized thymol analogues was also performed against tyrosinase protein (PDBID 2ZMX) to compare the binding affinities with IC50 values. The predicted binding affinities are in good agreement with the IC50 values as compound (6b) showed highest binding affinity -7.1 kcal/mol. The kinetic mechanism analyzed by Lineweaver-Burk plots exhibited that compound (4d) and (6b) inhibit the enzyme by two different pathways displayed mixed-type inhibition. The inhibition constants Ki calculated from Dixon plots for compounds (4d) and (6b) are 34 μM and 25 μM respectively. It was also found from kinetic analysis that derivative (6b) formed reversible enzyme inhibitor complex. It is propose on the basis of our investigation that title compound (6b) may serve as lead structure for the design of more potent tyrosinase inhibitors.
[The low number of reported adverse effects after vaccination against measles, mumps, rubella].

J. Taranger,B. Wiholm

1987-03-18

Abstract:
Structure-based Drug Design of New Cinnamic Acid Derivatives as Tyrosinase Inhibitors

Fayezeh Yousefnejad,Mohammad Hossein Sayahi,Ali Mazzam,Fatemeh Gholami,Nader Tanideh,Cambyz Irajie,Helia Tayebi,Fatemeh Rasekh,Bagher Larijani,Maliheh Barazandeh Tehrani,Mohammad Mahdavi,Aida Iraji

DOI: https://doi.org/10.2174/0115701786263337231227113513

2024-01-25

Letters in Organic Chemistry

Abstract:Abstract: Tyrosinase is a critical enzyme responsible for pigmentation disorders, and tyrosinase inhibition is an established strategy to treat hyperpigmentation. In the current study, cinnamic acidbased derivatives were designed and synthesized. All synthesized compounds were confirmed using IR, 1 HNMR, 13CNMR, and CNH analysis. The inhibitory potencies of all derivatives against tyrosinase were determined, and it was shown that 5m bearing para-chloro moiety exhibits an IC50 value of 77.62 μmol/L. Analysis of enzyme kinetic studies revealed that 5m is an uncompetitive inhibitor. In silico studies against tyrosinase predicted possible binding mode in the pocket such that 5m formed critical interactions with both Cu co-factors within the binding site. This study presents the potential of aryl-substituted cinnamic acids that can benefit various cosmetic formulations as depigmentation agents.

chemistry, organic
Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases

Hye Jin Kim,Hee Jin Jung,Young Eun Kim,Daeun Jeong,Hyeon Seo Park,Hye Soo Park,Dongwan Kang,Yujin Park,Pusoon Chun,Hae Young Chung,Hyung Ryong Moon

DOI: https://doi.org/10.3390/molecules29122887

IF: 4.6

2024-06-18

Molecules

Abstract:Based on the fact that substances with a β-phenyl-α,β-unsaturated carbonyl (PUSC) motif confer strong tyrosinase inhibitory activity, benzylidene-3-methyl-2-thioxothiazolidin-4-one (BMTTZD) analogs 1-8 were prepared as potential tyrosinase inhibitors. Four analogs (1-3 and 5) inhibited mushroom tyrosinase strongly. Especially, analog 3 showed an inhibitory effect that was 220 and 22 times more powerful than kojic acid in the presence of l-tyrosine and l-dopa, respectively. A kinetic study utilizing mushroom tyrosinase showed that analogs 1 and 3 competitively inhibited tyrosinase, whereas analogs 2 and 5 inhibited tyrosinase in a mixed manner. A docking simulation study indicated that analogs 2 and 5 could bind to both the tyrosinase active and allosteric sites with high binding affinities. In cell-based experiments using B16F10 cells, analogs 1, 3, and 5 effectively inhibited melanin production; their anti-melanogenic effects were attributed to their ability to inhibit intracellular tyrosinase activity. Moreover, analogs 1, 3, and 5 inhibited in situ B16F10 cellular tyrosinase activity. In three antioxidant experiments, analogs 2 and 3 exhibited strong antioxidant efficacy, similar to that of the positive controls. These results suggest that the BMTTZD analogs are promising tyrosinase inhibitors for the treatment of hyperpigmentation-related disorders.
Novel Anti-Melanogenic Compounds, (Z)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico Insights

Heejeong Choi,Il Young Ryu,Inkyu Choi,Sultan Ullah,Hee Jin Jung,Yujin Park,Yeongmu Jeong,YeJi Hwang,Sojeong Hong,In-Soo Yoon,Hwayoung Yun,Min-Soo Kim,Jin-Wook Yoo,Yunjin Jung,Pusoon Chun,Hyung Ryong Moon

DOI: https://doi.org/10.3390/molecules26164963

IF: 4.6

2021-08-17

Molecules

Abstract:To confirm that the β-phenyl-α,β-unsaturated thiocarbonyl (PUSTC) scaffold, similar to the β-phenyl-α,β-unsaturated carbonyl (PUSC) scaffold, acts as a core inhibitory structure for tyrosinase, twelve (Z)-5-(substituted benzylidene)-4-thioxothiazolidin-2-one ((Z)-BTTZ) derivatives were designed and synthesized. Seven of the twelve derivatives showed stronger inhibitory activity than kojic acid against mushroom tyrosinase. Compound 2b (IC50 = 0.47 ± 0.97 μM) exerted a 141-fold higher inhibitory potency than kojic acid. Kinetic studies’ results confirmed that compounds 2b and 2f are competitive tyrosinase inhibitors, which was supported by high binding affinities with the active site of tyrosinase by docking simulation. Docking results using a human tyrosinase homology model indicated that 2b and 2f might potently inhibit human tyrosinase. In vitro assays of 2b and 2f were conducted using B16F10 melanoma cells. Compounds 2b and 2f significantly and concentration-dependently inhibited intracellular melanin contents, and the anti-melanogenic effects of 2b at 10 μM and 2f at 25 μM were considerably greater than the inhibitory effect of kojic acid at 25 μM. Compounds 2b and 2f similarly inhibited cellular tyrosinase activity and melanin contents, indicating that the anti-melanogenic effects of both were due to tyrosinase inhibition. A strong binding affinity with the active site of tyrosinase and potent inhibitions of mushroom tyrosinase, cellular tyrosinase activity, and melanin generation in B16F10 cells indicates the PUSTC scaffold offers an attractive platform for the development of novel tyrosinase inhibitors.

chemistry, multidisciplinary,biochemistry & molecular biology
Multi‐functional tyrosinase inhibitors derived from kojic acid and hydroquinone‐like diphenols for treatment of hyperpigmentation: Synthesis and in vitro biological evaluation

Morteza Ashooriha,Mehdi Khoshneviszadeh,Maryam Kabiri,Ali Dehshahri,Bahareh Hassani,Mahsa Ansari,Saeed Emami

DOI: https://doi.org/10.1002/ardp.202400380

2024-10-29

Archiv der Pharmazie

Abstract:A series of multi‐functional tyrosinase inhibitors derived from kojic acid (KA) and hydroquinone‐like diphenols were synthesized using a conjugation strategy. The tyrosinase inhibitory and anti‐oxidant activities were improved in the multi‐functional agents such as 6i over the parent compound KA, being potentially useful in the treatment of skin disorders. A series of multi‐functional tyrosinase inhibitors derived from kojic acid (KA) and hydroquinone‐like diphenols were designed and synthesized using click chemistry. The in vitro enzymatic assay revealed that all compounds containing a free enolic structure showed excellent activity against tyrosinase (IC50 = 0.14–3.7 μM), being significantly more potent than KA. The most active compounds were catechol (6c) and α‐naphthol (6i) analogs with 138‐ and 96‐fold higher potency than KA. On the other hand, all free phenolic compounds (6a‐c and 6g‐j) derived from aromatic diols showed outstanding free radical scavenging activities superior to KA. Certainly, the α‐naphthol derivative 6i with IC50 = 10.1 μM was the most active anti‐oxidant, being as potent as quercetin. The SAR analysis indicated that the enolic head of the conjugate molecules mainly contributes to the anti‐tyrosinase activity, and the free phenolic part of the molecules can offer anti‐oxidant potency. The anti‐melanogenic assay of the most promising derivative, 6i, against melanoma (B16F10) cells demonstrated that the prototype compound 6i can significantly reduce the melanin content, more effectively than KA. By using a conjugation strategy, we have improved the tyrosinase inhibitory and radical scavenging activity in the multi‐functional agents such as 6i over the parent compound KA, being potentially useful in the treatment of hyperpigmentation and other skin disorders.

pharmacology & pharmacy,chemistry, medicinal, multidisciplinary
Biochemical and In Silico Studies on Triazole Derivatives as Tyrosinase Inhibitors: Potential Treatment of Hyperpigmentation Related Skin Disorders

Yusra Choudhary,Atia-Tul- Wahab,Humaira Zafar,Salman Siddiqui,Majid Khan,Khalid M Khan,Amer H Asseri,M Iqbal Choudhary,Atta-Ur- Rahman,Atia-tul- Wahab,Khalid M. Khan,Amer H. Asseri,M. Iqbal Choudhary,Atta-ur- Rahman

DOI: https://doi.org/10.2174/0115734064271581231219111952

2024-03-21

Medicinal Chemistry

Abstract:Introduction: Tyrosinase is a versatile, glycosylated copper-containing oxidase enzyme that mainly catalyzes the biosynthesis of melanin in mammals. Its overexpression leads to the formation of excess melanin, resulting in hyperpigmentary skin disorders, such as dark spots, melasma, freckles, etc. Therefore, inhibition of tyrosinase is a therapeutic approach for the treatment of hyperpigmentation. Method: The current study focused on evaluating tyrosinase inhibitory activities of triazole derivatives 1-20, bearing different substituents on the phenyl ring. 17 derivatives have shown a potent tyrosinase inhibition with IC 50 values between 1.6 to 13 μM, as compared to the standard drug, i.e., kojic acid (IC 50 = 24.1 ± 0.5 μM). Particularly, compounds 11 and 15 displayed 12 times more potent inhibitory effects than the kojic acid. Result: The structure-activity relationship revealed that substituting halogens at the C-4 position of the benzene ring renders remarkable anti-tyrosinase activities. Compounds 1-3 and 8 showed a competitive type of inhibition, while compounds 5, 11, and 15 showed a non-competitive mode of inhibition. Next, we performed molecular docking analyses to study the binding modes and interactions between the ligands (inhibitors) and the active site of the tyrosinase enzyme (receptor). Besides this, we have assessed the toxicity profile of inhibitors on the BJ human fibroblast cell line. Conclusion: The majority of the newly identified tyrosinase inhibitors were found to be noncytotoxic. The results presented herein form the basis of further studies on triazole derivatives as potential drug leads against tyrosinase-related diseases.

chemistry, medicinal

Recovery from alpha coma after decompression sickness complicated by spinal cord lesions at cervical and midthoracic levels.

A System for Probabilistic Inductive Answer Set Programming

Design, synthesis, QSAR modelling and molecular dynamic simulations of N-tosyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors

Design, synthesis, and in vitro and in silico study of 1-benzyl-indole hybrid thiosemicarbazones as competitive tyrosinase inhibitors

Design, Synthesis, Structural Insights, Tyrosinase Inhibition, and Sun Protection Factor of New Thiosemicarbazone Derivatives

Design, synthesis, and molecular dynamics simulation studies of some novel kojic acid fused 2-amino-3-cyano-4H-pyran derivatives as tyrosinase inhibitors

Design and synthesis of novel dihydropyridine- and benzylideneimine-based tyrosinase inhibitors

Synthesis and biological assessment of novel 4H-chromene-3-carbonitrile derivatives as tyrosinase inhibitors

Nitrophenylpiperazine derivatives as novel tyrosinase inhibitors: design, synthesis, and in silico evaluations

[Two cases of stroke associated with the use of finasteride, an approved drug for male-pattern hair loss in Japan].

Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study

Inhibitory Effects, Fluorescence Studies, and Molecular Docking Analysis of Some Novel Pyridine-Based Compounds on Mushroom Tyrosinase

Design and synthesis of novel hydroxypyridinone derivatives as potential tyrosinase inhibitors

Design, Synthesis, and Anti-Melanogenic Activity of 2-Mercaptomethylbenzo[d]imidazole Derivatives Serving as Tyrosinase Inhibitors: An In Silico, In Vitro, and In Vivo Exploration

Kinetic and in silico studies of novel hydroxy-based thymol analogues as inhibitors of mushroom tyrosinase

[The low number of reported adverse effects after vaccination against measles, mumps, rubella].

Structure-based Drug Design of New Cinnamic Acid Derivatives as Tyrosinase Inhibitors

Investigation of the Efficacy of Benzylidene-3-methyl-2-thioxothiazolidin-4-one Analogs with Antioxidant Activities on the Inhibition of Mushroom and Mammal Tyrosinases

Novel Anti-Melanogenic Compounds, (Z)-5-(Substituted Benzylidene)-4-thioxothiazolidin-2-one Derivatives: In Vitro and In Silico Insights

Multi‐functional tyrosinase inhibitors derived from kojic acid and hydroquinone‐like diphenols for treatment of hyperpigmentation: Synthesis and in vitro biological evaluation

Biochemical and In Silico Studies on Triazole Derivatives as Tyrosinase Inhibitors: Potential Treatment of Hyperpigmentation Related Skin Disorders